Alkeon Capital Management - PMV PHARMACEUTICALS INC ownership

PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of PMV PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,413,122
+55.6%
2,347,414
+58.6%
0.03%
+62.5%
Q2 2023$9,263,968
+40.6%
1,479,867
+7.1%
0.02%
+6.7%
Q1 2023$6,588,940
-45.3%
1,381,329
-0.3%
0.02%
-68.1%
Q4 2022$12,051,823
-33.2%
1,385,267
-8.7%
0.05%
-19.0%
Q3 2022$18,055,000
-16.6%
1,517,246
-0.2%
0.06%0.0%
Q2 2022$21,659,000
-35.0%
1,519,935
-5.0%
0.06%
-13.4%
Q1 2022$33,303,000
-9.9%
1,599,5530.0%0.07%
-1.5%
Q4 2021$36,949,000
-12.7%
1,599,553
+12.7%
0.07%
-4.2%
Q3 2021$42,303,000
+9.8%
1,419,553
+25.9%
0.07%
+24.6%
Q2 2021$38,513,000
+3.7%
1,127,418
-0.2%
0.06%
+3.6%
Q1 2021$37,155,000
-46.4%
1,129,681
+0.2%
0.06%
-51.3%
Q4 2020$69,331,000
+311.1%
1,127,151
+137.3%
0.11%
+264.5%
Q3 2020$16,863,000475,0000.03%
Other shareholders
PMV PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,614,911$19,217,00059.24%
Euclidean Capital LLC 2,336,909$27,809,00025.82%
OUP Management Co., LLC 989,232$11,772,00018.33%
Nextech Invest Ltd. 1,385,807$16,491,0005.33%
Boxer Capital, LLC 3,163,795$37,649,0002.12%
PERSONAL CFO SOLUTIONS, LLC 550,342$6,549,0001.64%
Orbimed Advisors 6,563,077$78,101,0001.45%
RTW INVESTMENTS, LP 4,356,920$51,847,0001.20%
ACUTA CAPITAL PARTNERS, LLC 154,500$1,839,0000.79%
Monarch Partners Asset Management LLC 210,370$2,503,0000.75%
View complete list of PMV PHARMACEUTICALS INC shareholders